Patent details
LUC00245 Product Name: Composition contenant à la fois de l'estradiol (17β-estradiol), éventuellement sous forme d'un sel, hydrate ou solvate pharmaceutiquement acceptable de celui-ci (y compris sous forme hémihydratée), et de la progestérone
Basic Information
- Publication number:
- LUC00245
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP128508454
- Legal Status:
- Invalid
- Application number:
- LUC00245
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
1
- Marketing Authorization Number:
- BE582231
- Marketing Authorization Type:
- Marketing Authorization Date:
- 06/04/2021
- Marketing Authorization Status:
- Claimed
- Marketing Authorization Country:
- Belgium (BE)
2
- Marketing Authorization Number:
- 2021070140
- Marketing Authorization Type:
- Marketing Authorization Date:
- 01/07/2021
- Marketing Authorization Status:
- Claimed
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 08/12/2021
- First Marketing Authorization date:
- 06/04/2021
- Grant date:
- Activation date:
- Publication date:
- 10/12/2021
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 06/04/2036
- SPC Extension Expiration:
- 06/04/2036
- Rejection date:
- Withdrawal date:
- 19/10/2023
Owner
- From:
- 08/12/2021
- Name:
- TherapeuticsMD, Inc.
- Address:
- 951 Yamato Road, Suite 220, Boca Raton, FL 33431, United States (US)
Agent
- Name:
- CABINET MURGITROYD
- From:
- 08/12/2021
- Address:
- Le Fairway, Bâtiment C, 980 Avenue Roumanille, 06410, Biot, Sophia-Antipolis , France (FR)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2022/01
- Publication date:
- 03/01/2022
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- VRV
- Bulletin edition number:
- 2024/01
- Publication date:
- 05/01/2024
- Description:
- Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates
| Filing date | Document type | Number of pages |
|---|---|---|
| 10/12/2021 | Publication | 1 |
| 08/12/2021 | General Document | 22 |
| 08/12/2021 | Marketing authorization | 5 |
| 08/12/2021 | Summary of the product caracteristics | 20 |
| 10/12/2021 | Outgoing Correspondence | 1 |
| 08/12/2021 | Marketing authorization | 2 |
| 08/12/2021 | Application Form | 6 |
| 19/10/2023 | Incoming Correspondence (Post) | 1 |
| 14/12/2023 | Outgoing Correspondence | 1 |